Dancing, What you suggest is a full blown gambit. If we don’t win, then what? We’ve risked a lot (more) on another unknown. The biggest unknown should have been R-IT trial...
Now that we know the science is real and that we are (as of now) dead in US market, the highest (certain) value capture for shareholders is to sell our valuable assets and capture more value thru CVR. This is a win/win for all parties.
If we go the route you suggest it could certainly work if appeal is won. I just don’t see how it’s best if we lose.
News 
Market Data 
Discover 
